These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22227071)

  • 1. Lower plasma NAMPT/visfatin levels are associated with impaired hepatic mitochondrial function in non-diabetic obese women: a potential link between obesity and non-alcoholic fatty liver disease.
    Ruiz JR; Lasa A; Simon E; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):e1-2. PubMed ID: 22227071
    [No Abstract]   [Full Text] [Related]  

  • 2. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.
    Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V
    Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; Sagrado MG; Conde R; Velasco MC; Alvarez T; Pacheco D; González JM
    Dig Dis Sci; 2009 Aug; 54(8):1772-7. PubMed ID: 19005759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease].
    Wen H; Wang HJ; Dong B; Ma J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):269-72. PubMed ID: 22613376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol prevents the progression of fatty liver in MSG obese mice.
    Yoshida T; Yoshioka K; Sakane N; Umekawa T; Kondo M
    Exp Clin Endocrinol Diabetes; 1995; 103(2):119-22. PubMed ID: 7553075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol.
    Jin H; Jiang B; Tang J; Lu W; Wang W; Zhou L; Shang W; Li F; Ma Q; Yang Y; Chen M
    Diabetes Res Clin Pract; 2008 Mar; 79(3):412-8. PubMed ID: 18241953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of increased visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Cienfuegos JA; Salvador J; Frühbeck G
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):245-53. PubMed ID: 20106640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].
    Romanowska A; Lebensztejn DM
    Pol Merkur Lekarski; 2010 Jun; 28(168):459-61. PubMed ID: 20642104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis in obese patients with fatty livers.
    Watanabe A; Kobayashi M; Yoshitomi S; Nagashima H
    J Med; 1989; 20(5-6):357-62. PubMed ID: 2628518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women.
    Unlütürk U; Harmanci A; Yildiz BO; Bayraktar M
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):469-74. PubMed ID: 19650786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin expression is elevated in normal human pregnancy.
    Morgan SA; Bringolf JB; Seidel ER
    Peptides; 2008 Aug; 29(8):1382-9. PubMed ID: 18524416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.